SG Americas Securities
SLRN

SG Americas Securities’s ACELYRIN SLRN Stock Holding History

SG Americas Securities’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,110
Closed -$67K – 3530
2025
Q1 		$67K Sell
27,110
-3,378
-11% -$8.03K ﹤0.01% 3168
2024
Q4 		$96K Buy
30,488
+3,733
+14% +$18.1K ﹤0.01% 2759
2024
Q3 		$132K Buy
26,755
+15,101
+130% +$78K ﹤0.01% 2839
2024
Q2 		$51K Buy
+11,654
New +$54.6K ﹤0.01% 2671
2024
Q1 		– Sell
-14,741
Closed -$110K – 3402
2023
Q4 		$110K Buy
+14,741
New +$126K ﹤0.01% 2695

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SG Americas Securities's SLRN Position: Q2 2025 in Review

SG Americas Securities sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 27,110 shares — an estimated $67K sold.

SG Americas Securities first reported a position in SLRN in Q4 2023 and held it in 5 quarters. The position peaked at $132K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • SG Americas Securities reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 27,110 ACELYRIN shares in Q2 2025, an estimated $67K.
  • SG Americas Securities first reported a position in ACELYRIN in Q4 2023 and held it in 5 quarters.
  • SG Americas Securities's ACELYRIN position peaked at $132K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.